`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`COALITION FOR AFFORDABLE DRUGS VII LLC,
`Petitioner,
`
`v.
`
`POZEN INC.,
`Patent Owner.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2015-01680
`Patent 8,852,636
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S UPDATED MANDATORY NOTICES
`
`
`
`
`
`Pursuant to 37 C.F.R. §§ 42.8(a)(3) and (b)(1), Petitioner provides the
`
`IPR2015-01680
`Patent 8,852,636
`
`
`
`following updated identification of real parties-in-interest:
`
`Real Parties-In-Interest
`
`Petitioner certifies that Coalition For Affordable Drugs VII LLC (“CFAD”);
`
`Hayman Credes Master Fund, L.P. (“Credes”); Hayman Orange Fund SPC –
`
`Portfolio A (“HOF”); Hayman Capital Master Fund, L.P. (“HCMF”); Hayman
`
`Capital Management, L.P. (“HCM”); Hayman Offshore Management, Inc.
`
`(“HOM”); Hayman Investments, L.L.C. (“HI”); nXn Partners, LLC (“nXnP”); IP
`
`Navigation Group, LLC (“IPNav”); J Kyle Bass; and Erich Spangenberg
`
`(collectively, “RPI”) are the real parties-in-interest. The RPI certify the following:
`
`CFAD is a wholly owned subsidiary of Credes, HOF, and HCMF. Credes is a
`
`limited partnership. HOF is a segregated portfolio company. HCMF is a limited
`
`partnership. HCM is the general partner and investment manager of Credes and
`
`HCMF. HCM is the investment manager of HOF. HOM is the administrative
`
`general partner of Credes and HCMF. HI is the general partner of HCM. J Kyle
`
`Bass is the sole member of HI and sole shareholder of HOM. CFAD, Credes,
`
`HOF, and HCMF act, directly or indirectly, through HCM as the general partner
`
`and/or investment manager of Credes, HOF, and HCMF. nXnP is a paid
`
`consultant to HCM. Erich Spangenberg is the Manager and majority member of
`
`nXnP. IPNav is a paid consultant to nXnP. Erich Spangenberg is the Manager and
`
`1
`
`
`
`
`majority member of IPNav. Other than HCM and J Kyle Bass in his capacity as
`
`IPR2015-01680
`Patent 8,852,636
`
`the Chief Investment Officer of HCM and nXnP and Erich Spangenberg in his
`
`capacity as the Manager/CEO of nXnP, no other person (including any investor,
`
`limited partner, or member or any other person in any of CFAD, Credes, HOF,
`
`HCMF, HCM, HOM, HI, nXnP, or IPNav) has authority to direct or control (i) the
`
`timing of, filing of, content of, or any decisions or other activities relating to this
`
`petition or (ii) any timing, future filings, content of, or any decisions or other
`
`activities relating to the future proceedings related to this petition. All of the costs
`
`associated with this petition are expected to be borne by HCM, CFAD, Credes,
`
`Respectfully submitted,
`
`
`
`
`
`/Amy E. LaValle/
`Amy E. LaValle (Reg. No. 51,092)
`Jerry C. Harris, Jr. (Reg. No. 66,822)
`WICK PHILLIPS GOULD & MARTIN, LLP
`3131 McKinney Avenue, Suite 100
`Dallas, TX 75204
`(214) 692-6200 (phone)
`(214) 692-6255 (fax)
`amy.lavalle@wickphillips.com
`jerry.harris@wickphillips.com
`
`Counsel for Petitioner
`Coalition for Affordable Drugs VII LLC
`
`2
`
`HOF, and/or HCMF.
`
`
`
`Date: January 20, 2016
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`IPR2015-01680
`Patent 8,852,636
`
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on January 20, 2016 a
`
`copy of the foregoing PETITIONER’S UPDATED MANDATORY NOTICES
`
`was provided via email to the following counsel of record for Patent Owner:
`
`Counsel for Horizon Pharma, Inc.
`Back-Up Counsel
`Lead Counsel
`Thomas A. Blinka, Ph.D.
`Ricardo Rodriguez
`COOLEY LLP
`COOLEY LLP
`1299 Pennsylvania Avenue, NW
`3175 Hanover Street
`Suite 700
`Palo Alto, CA 94304-1130
`Washington, DC 20004-2400
`Tel: (650) 843-5046
`Tel: (202) 842-7800
`Fax: (650) 843-7400
`Fax: (202) 842-7899
`rr@cooley.com
`tblinka@cooley.com
`zIPR2015-01680@cooley.com
`Back-Up Counsel
`Back-Up Counsel
`Lauren L. Stevens, Ph.D.
`Dennis Bennett
`GLOBAL PATENT GROUP, LLC
`GLOBAL PATENT GROUP, LLC
`1005 N. Warson Road, Suite 404
`1005 N. Warson Road, Suite 404
`St. Louis, MO 63132
`St. Louis, MO 63132
`Tel: (650) 387-3813
`Tel: (314) 812-8018
`Fax: (314) 685-2300
`Fax: (314) 685-2300
`lstevens@globalpatentgroup.com
`dennisbennett@globalpatentgroup.com
`Counsel for Pozen Inc.
`Back-Up Counsel
`Margaret J. Sampson, Ph.D.
`BAKER BOTTS LLP
`98 San Jacinto Blvd., Suite 1500
`Austin, TX 78701-4078
`Tel: (512) 322-2552
`Fax: (512) 322-3652
`margaret.sampson@bakerbotts.com
`
`Lead Counsel
`Stephen M. Hash, Ph.D.
`BAKER BOTTS LLP
`98 San Jacinto Blvd., Suite 1500
`Austin, TX 78701-4078
`Tel: (512) 322-2587
`Fax: (512) 322-3687
`stephen.hash@bakerbotts.com
`PozenVimovoBB@bakerbotts.com
`
`3
`
`
`
`IPR2015-01680
`Patent 8,852,636
`
`
`
`
`
`
`/Amy E. LaValle/
`Lead Counsel for Petitioner
`Coalition for Affordable Drugs VII LLC
`
`
`
`4
`
`
`Back-Up Counsel
`Jeffrey S. Gritton
`BAKER BOTTS LLP
`98 San Jacinto Blvd., Suite 1500
`Austin, TX 78701-4078
`Tel: (512) 322-2624
`Fax: (512) 322-3652
`Jeff.Gritton@bakerbotts.com
`
`
`
`Date: January 20, 2016